We investigated the transgalactosylation reaction of chlorphenesin (CPN) using β-galactosidase (β-gal)-containing Escherichia coli (E. coli) cells, in which galactose from lactose was transferred to CPN. The optimal CPN concentration for CPN galactoside (CPN-G) synthesis was observed at 40 mM under the conditions that lactose and β-gal (as E. coli cells) were 400 g/l and 4.8 U/ml, respectively, and the pH and temperature were 7.0 and 40 o C, respectively. The time-course profile of CPN-G synthesis under these optimal conditions showed that CPN-G synthesis from 40 mM CPN reached a maximum of about 27 mM at 12 h. This value corresponded to an about 67% conversion of CPN to CPN-G, which was 4.47-5.36-fold higher than values in previous reports. In addition, we demonstrated by thin-layer chromatography to detect the sugar moiety that galactose was mainly transferred from lactose to CPN. Liquid chromatography-mass spectrometry revealed that CPN-G and CPN-GG (CPN galactoside, which accepted two galactose molecules) were definitively identified as the synthesized products using β-gal-containing E. coli cells. In particular, because we did not use purified β-gal, our β-gal-containing E. coli cells might be practical and cost-effective for enzymatically synthesizing CPN-G. It is expected that the use of β-gal-containing E. coli will be extended to galactose derivatization of other drugs to improve their functionality.
β-Galactosidase (β-gal) has been recently used to enzymatically synthesize several galactoside derivatives [12, 13, 15, 18] as well as to perform lactose hydrolysis and galactooligosaccharide (GOS) synthesis [4, 5] . Galactoside derivatives are synthesized under conditions of a high lactose concentration; that is, through a reverse hydrolysis reaction of β-gal in which galactose is transferred from lactose to acceptor molecules (transgalactosylation). This reaction has been conducted to overcome the drawbacks of acceptor molecule functionality. Several studies have reported the decreased toxicity and increased solubility of glycoside drug derivatives [2, 3] .
We have been conducting studies on the use of recombinant Escherichia coli (E. coli) β-gal, which exists as an active inclusion body (IB) in cells [6, 7] . β-Galcontaining E. coli cells can be used in immobilized cell reactor systems [11, 20, 21] . Therefore, in this study, we investigated the transgalactosylation reaction of chlorphenesin (CPN , Fig. 1A) ; that is, the transfer reaction of galactose from lactose to CPN using β-gal-containing E. coli. CPN is generally used as a preservative in cosmetics, and some reports have indicted its side-effects [19] . CPN is also used as CPN carbamate, which is a muscle relaxant used to treat injuries and other painful muscular conditions [9] . In this study, we expected that this galactoside derivative of CPN (CPN-G) might circumvent the side-effects of CPN due to galactosylation of CPN. Experiments on the optimal GOS synthesis conditions using β-gal-containing E. coli were conducted in our previous study, and we demonstrated that transgalactosylation could be conducted using β-galcontaining E. coli [10] . In addition, we predicted that it is possible to use our β-gal-containing E. coli for the transgalactosylation reaction [10] .
This study is the first investigation on CPN-G synthesis using E. coli β-gal, although two previous reports showed CPN-G synthesis by β-gal from yeast [1] and fungi [17] . The objectives of this study were to identify the CPN-G molecule in the enzymatic reaction mixture using β-galcontaining E. coli, to investigate the optimal conditions for CPN-G synthesis, and to verify that galactose was transferred from lactose to CPN during the transgalactosylation reaction by β-gal-containing E. coli. Because it is generally accepted *Corresponding author Phone: +82-43-820-5246; Fax: +82-43-820-5272; E-mail: khjung@cjnu.ac.kr that β-gal catalyzes the transfer of galactose from lactose to an acceptor molecule, as observed in GOS and galactoside prodrug synthesis, we began this study under the assumption that galactose might be transferred from lactose by β-galcontaining E. coli; that is, the galactoside derivative of CPN was synthesized in β-gal-containing E. coli.
CPN was kindly supplied by CosMol (Siheung, Korea). β-Gal from Kluyveromyces lactis (K. lactis) (Lactozym 3000 L HP-G; Novo Nordisk A/S, Bagsvaerd, Denmark) was kindly supplied by EnzymTech (Yongin, Korea). Thin-layer chromatography (TLC) plates (Partisil K5F) were purchased from Whatman (Maidstone, UK). LArabibose, D-fucose, phosphomolybdic acid, α-naphtol, and silica gel (pore size 60 Å, 200-400 mesh) were purchased from Sigma-Aldrich (St. Louis, MO, USA). Ce(SO 4 ) 2 ·4H 2 O was obtained from Junsei Chemical (Tokyo, Japan). All other reagents were of reagent grade.
We used recombinant β-gal-expressing E. coli under the control of the araBAD promoter system. The β-gal gene was cloned into the pBAD/Myc-His/lacZ (7.2 kb) vector using the pBAD/Myc-His Expression Kit (Invitrogen, Carlsbad, CA, USA). E. coli MC1061 was used as the expression host, and the detailed information on E. coli β-gal and the cloning procedure were as described previously [6, 7, 10, 11, 21] . One unit of recombinant E. coli β-gal was defined as the amount of β-gal that was capable of producing o-nitrophenol from o-nitrophenyl-β-D-galactoside at 37 o C and pH 7.0. The detailed β-gal assay protocol has been described previously [6, 7, 10] .
Cultures were conducted in a 2.5 L jar fermentor (Applikon Biotechnology, Schiedam, The Netherlands) with a working volume of 1.0 L under conditions described previously [6, 7, 10, 11, 21] . L-Arabinose was induced at 0.05% after 3 h of culture, in which 0.01% D-fucose was added after 3.5 h. Cells were harvested after 5.5 h, collected by centrifugation, and the optical density at 600 nm was adjusted to 2.0 using phosphate-buffered saline. A 1.5 ml aliquot of this standardized cell suspension was centrifuged for each sample, and the resulting cell pellets were stored at -20 o C. The stored E. coli samples were used for their enzymes in the CPN transgalactosylation reaction.
We examined the optimal CPN concentration (10-50 mM) under the conditions that 400 g/l lactose and 4.8 U/ml β-gal (as E. coli cells) were prepared in 10 ml of All samples were diluted 5-fold before TLC analyses. The optimal conditions, except for CPN concentration, are indicated in the box. All measurements were conducted three times using the same sample, and the average and standard deviation were calculated. (C) TLC for CPN-G(p) synthesis using 10-50 mM CPN at zero and 24 h. All samples were diluted 2-fold before TLC analysis.
50 mM phosphate buffer (pH 7.0) in a 15 ml conical tube, to investigate the optimal conditions for CPN-G synthesis. Then, CPN-G synthesis was conducted in a shaking incubator (40 o C, 100 rpm) for 24 h and CPN-G was quantified by TLC. Because CPN synthesis was monitored by TLC, we presumptively designated the synthesized galactose derivative of CPN as CPN-G(p). The amounts of synthesized CPN-G and residual CPN during enzymatic CPN-G synthesis under optimal conditions were quantified using high-performance liquid chromatography (HPLC). When β-gal (10 U/ml) from K. lactis (Lactozym) was used to synthesize CPN-G, the CPN-G synthesis was conducted under the optimal conditions described by Bridiau et al. [1] .
TLC plates of 20 × 10 cm were used for TLC analyses, and the sample loading volume was 1.0 µl. Ethyl acetate: methanol: distilled water = 17:2:1 (v/v) was used for the CPN-G analysis [16] , and acetonitrile: water = 85:15 (v/v) was used for the sugar-moiety analysis [21] . The staining solution to visualize CPN-G contained 2.5 g of phosphomolybdic acid, 1 g of Ce(SO 4 ) 2 ·4H 2 O, and 6 ml of H 2 SO 4 in 100 ml of distilled water [16] , and the staining solution for visualizing the sugar moiety contained 0.5% α-naphtol and 5% H 2 SO 4 in ethanol [21] . After developing the samples, the TLC plates were soaked in staining solution and then dried in an oven at 80 o C to visualize the bands. If necessary, the scanned images of the TLC bands were converted to peaks using the AlphaEase FC software (Alpha Innotech, San Leonardo, CA, USA), and their quantities were calculated. An 8 ml aliquot of the enzyme reaction mixture was loaded onto the surface of the silica gel column, and the mobile phase flowed continuously by gravity to purify CPN-G based on the protocol of Scheckermann et al. [17] . HPLC (YL 9100 system; Younglin, Seoul, Korea) was used to quantify CPN and CPN-G in a sample volume of 20 µl. The mobile phase was 30% acetonitrile, the flow rate was 1.0 ml/min, and a C 18 column (Hypersil GOLD, 150 × 4.6 mm, particle size 5 µm; Thermo Scientific, Rockford, IL, USA) was used [1] . A UV/Vis detector detected CPN and CPN-G at 280 nm. After the 12 h enzyme reaction time had elapsed, the reaction mixture was applied to a liquid chromatograph-mass spectrometer (LCMS-IT-TOF; Shimadzu Corp., Tokyo, Japan). The LC conditions were the same as those for HPLC.
The galactoside derivative is generally synthesized by reverse hydrolysis with a high lactose concentration, and the galactose from lactose is transferred to the hydroxyl group (-OH) of the acceptor molecule. The galactose transfer reaction (so-called transgalactosylation) to CPN by β-gal-containing E. coli was investigated to synthesize CPN-G. In our previous study, the optimal conditions were explored in terms of lactose concentration, pH, the amount of β-gal (as E. coli cells), and temperature [10] . Based on the same protocol, we investigated the optimal conditions to synthesize CPN-G from CPN by β-gal-containing E. coli, although the detailed procedures and results are not described in this study. We observed that the optimal conditions for CPN-G synthesis were 400 g/l lactose, pH 7.0, 4.8 U/ml β-gal (as E. coli), and 40 o C, respectively, except for the optimal CPN concentration. In particular, when comparing GOS synthesis using β-gal-containing E. coli with that of this study, CPN as a galactose acceptor was added to the reaction mixture, and it was necessary to optimize the CPN concentration. Then, we investigated the optimal CPN-G(p) synthesis when CPN concentrations in the reaction mixture were increased from 10 to 50 mM (Fig. 1B) . However, the water solubility of CPN is <49.34 mM. As the CPN concentration was increased, CPN-G(p) synthesis during 24 h increased hyperbolically and reached a plateau (Fig. 1B) . This result was probably associated with the water solubility of CPN. No remarkable increase in CPN-G(p) synthesis was observed with >40 mM CPN, and a CPN precipitate was sometimes observed during CPN-G(p) synthesis when 50 mM CPN was used. In addition, CPN and CPN-G(p) spots were observed in the TLC results shown in Fig. 2C . Therefore, we adopted 40 mM CPN as an optimal concentration for CPN-G(p) synthesis using β-gal-containing E. coli. If it became necessary to increase the CPN-G conversion yield from CPN, it was deduced that both the organic solvent and immobilized cell systems would be applied to our β-gal-containing E. coli to improve the CPN solubility. This strategy has already been reported for β-gal [8, 14] .
We investigated the time-course profile of CPN-G synthesis under optimal conditions. As shown in Fig. 2A , CPN-G synthesis increased until 12 h, and then decreased gradually. At that time, residual CPN decreased from 40 mM and decreased gradually after 12 h until an elapsed time of 36 h. Maximum CPN-G synthesis was about 27 mM at 12 h, and this value corresponded to about 67% conversion of CPN to CPN-G. Simultaneous decreases in CPN-G and CPN after 12 h probably resulted from the secondary conversion of CPN-G to CPN-GG (CPN galactoside, which accepted two galactose molecules). That is, there was a continuous synthesis from CPN-G to CPN-GG by β-gal-containing E. coli after an elapsed time of 12 h. Bridiau et al. [1] reported that the conversion from CPN to CPN-G by β-gal from K. lactis (Lactozym 3000 L HP-G) was 15%. Additionally, Scheckermann et al. [17] reported a 12.5% conversion of CPN to CPN-G by β-gal from Aspergillus oryzae. Therefore, our conversion percentage from CPN to CPN-G was about 4.47-5.36-fold higher than that of Bridiau et al. [1] and Scheckermann et al. [17] . Figs. 2B and 2C show that CPN-G(p) synthesis by β-galcontaining E. coli was remarkably superior to that by β-gal from K. lactis (Lactozym), although the amount of β-galcontaining E. coli used (4.8 U/ml) in the synthesis was noticeably less than that of Lactozym (10 U/ml).
Although two studies have reported on CPN-G synthesis [1, 17] , our conversion percentage from CPN to CPN-G was the highest. In addition, we used 4.8 U/ml β-gal (as E. coli) for CPN-G synthesis, and 10 U/ml Lactozym was used under optimal conditions. Based on our previous study, it was deduced that the activity of E. coli β-gal IBs was enhanced by partial repression after inducing Larabinose, in which partial repression occurred by adding D-fucose after induction [6] . Although it is necessary to compare our E. coli β-gal and Lactozym intensively and quantitatively, this superior CPN-G synthesis by β-galcontaining E. coli might be a remarkable achievement that resulted from preparing E. coli containing active β-gal IBcontaining cells [6, 7] .
We simultaneously characterized the synthesized CPN-G by TLC and LC-MS analyses when the optimal conditions and time-course profile for CPN-G synthesis were investigated as shown in Figs. 1 and 2 . We first investigated which sugar moiety was transferred from lactose to CPN. For this experiment, TLC was conducted to detect the sugar moiety as shown in Fig. 3 , in which only the glucose, galactose, lactose, CPN-G, and CPN-GG but not CPN spots were visualized. We used the samples from Fig. 2A in Fig. 3. CPN-G (arrow 1) , CPN-GG (arrow 2), glucose (arrow 3), and galactose (arrow 4) were detected by TLC until 36 h. The spots shown by arrows 1 and 2 in Fig. 3 indicate CPN-G and CPN-GG synthesis, particularly CPN-GG synthesis from CPN-G during the latter part of the reaction. Interestingly, we found that the galactose spots were smaller than the glucose spots in Fig. 3 . This result definitively demonstrated that galactose was transferred from lactose to CPN and CPN-G. Therefore, although we assumed that galactose was transferred to CPN from lactose at the beginning of the study, these TLC data (A) Time-course profiles of CPN and CPN-G during CPN-G synthesis under optimal conditions using β-gal-containing E. coli. CPN and CPN-G were analyzed by HPLC. Conversion indicates the percent conversion from 40 mM CPN to CPN-G. The sample indicated by the arrow was used for LC-MS analyses. All measurements were conducted three times using the same sample, and the average and standard deviation were calculated. Error bars are sometimes hidden by the symbols, because the standard deviations were very small. (B) TLC of CPN-G(p) synthesis using β-gal-containing E. coli under optimal conditions during 0-36 h; samples are from panel A. (C) TLC of CPN-G(p) synthesis using Lactozym 3000 L HP-G, in which the CPN-G(p) synthesis was conducted under the optimal conditions described in Bridiau et al. [1] . In panels B and C, Glu, Gal, Lac, and CPN indicate 1% standards of glucose, galactose, lactose, and CPN, respectively. Samples were not diluted, and arrows indicate the CPN-G(p) spots.
provide direct evidence for the transfer of galactose to CPN. Experiments using nuclear magnetic resonance (NMR) spectroscopy, as well as a β-gal hydrolysis of CPN-G, as observed in our previous study [10] , are needed to obtain additional direct evidence for the transfer of galactose to CPN. Although we do not know which monosaccharide (glucose or galactose) was transferred, we determined temporarily that galactose was the transferred monosaccharide, based on the Fig. 3 data, because no reports have indicated that glucose is transferred to an acceptor molecule when β-gal is used in the transgalactosylation reaction.
As shown in Fig. 4A , the reaction mixture of Fig. 2A was separated as six peaks on the LC chromatogram, and CPN was identified as the CPN standard and peaks 1 and 2 were identified as the sodium adduct ion of CPN-G Fig. 3 . TLC for detecting the sugar moiety.
Samples were from Fig. 2A. CPN-G, CPN (387.0795) (Fig. 4B) and CPN-GG (549.1333) (Fig. 4C) Fig.  4A that appear in the LC chromatogram before peak 2. As a result, CPN-G and CPN-GG were identified in the reaction mixture by LC-MS. In addition, identifying CPN-GG in the reaction mixture definitively demonstrated that CPN-GG existed in the reaction mixture, and that the decrease in CPN-G after 12 h in Fig. 2A probably resulted from the synthesis of CPN-GG from CPN-G; that is, additional transfer of galactose to CPN-G. In particular, in two previous reports [1, 17] , the position of the covalent bond between CPN and galactose was proposed as a preferred structure, in which galactose is covalently bound with a primary alcohol group. Thus, it was probable that our CPN-G had the same covalent linkage between CPN and galactose.
In conclusion, we verified that β-gal-containing E. coli could successfully transfer galactose from lactose to CPN, resulting in CPN-G. This is the first time that CPN-G has been synthesized using E. coli β-gal. The conversion percentage from CPN to CPN-G was about 67%, which is remarkably higher when compared with that of two previous reports [1, 17] . In particular, because we did not use purified β-gal, it might be deduced that our β-galcontaining E. coli is practical and cost-effective for CPN-G enzymatic synthesis. However, it will be necessary to further improve the enzymatic CPN-G synthesis and understand this process by improving the conversion yield by increasing the CPN solubility using an organic solvent system, compiling direct evidence as to whether galactose was transferred to CPN and which galactose hydroxyl group was transferred to CPN, as well as changes in the minimal inhibitory concentration (MIC) and toxicity between CPN and CPN-G. The last topic (changes of MIC and toxicity) is crucial for driving future CPN-G synthesis research.
In previous studies [10, 11] , we expected that the β-galcontaining E. coli would be useful for transgalactosylation and investigated the enzymatic synthesis of GOS using β-gal-containing E. coli. As shown in this study, we expect that the usefulness of these β-gal-containing E. coli will be extended to synthesize galactoside derivatives of drugs to improve drug functionality.
